Farnell Colleagues cycle to Chicago to raise vital funds for Epilepsy Research UK


Epilepsy Research UK is delighted to announce that a group of colleagues from our long-standing corporate partner Farnell have completed a virtual cycle challenge from their office in Leeds to their Head Office in Chicago during October 2020. Over the period, Farnell colleagues pedalled 4,000 miles and raised £2,200.

Chief Executive Maxine Smeaton says “We are so grateful to Farnell for their incredible support over the past 15 years. This is such a fantastic way of continuing to drive innovations for people with epilepsy during lockdown.”

Simon Meadmore, Global Head of IP&E at Farnell says “This year has proven challenging for everyone, yet we are aware that for charities such as Epilepsy Research UK, the challenge they face every day does not go away just because we are dealing with a global pandemic. We have a longstanding relationship with the charity, having raised £175,000 over our 15 years of partnership, and were committed to supporting them again this year. Our virtual cycling challenge was a great way to raise essential funds, whilst promoting health and wellbeing for our team.”

The virtual cycling challenge was also supported by Farnell’s CPC business, who sponsored the event and provided prizes to participants.

The support from Farnell came during the month where Epilepsy Research UK launched the ‘#ALifeInterrupted’ campaign to highlight the disruptive, interruptive impact of epilepsy. The campaign also raises awareness of the inequalities in research funding of one of the most common serious neurological conditions as well as calls on people affected by epilepsy to help shape the future of research.

To learn more about Epilepsy Research UK and ‘#ALifeInterrupted’ campaign please visit www.epilepsyresearch.org.uk/ALifeInterrupted

A life free from epilepsy is possible. But only through research.


About us

Farnell is a global technology leader with over 80 years in the high service distribution of technology products and solutions for electronic system design, production, maintenance and repair. Farnell uses this experience to support its broad customer base, from hobbyists to engineers, maintenance engineers and buyers as ‘The Development Distributor’, working with leading brands and start-ups to develop new products for market, and supporting the industry as it seeks to develop the current and next generation of engineers.

Farnell trades as Farnell in Europe, Newark in North America, and element14 throughout Asia Pacific. Farnell's global businesses are supported by a global supply chain of more than 3,500 suppliers and has an extensive inventory profile developed to anticipate and meet the needs of innovative customers everywhere. Farnell also sells direct to consumers through a network of resellers, and its CPC business in the UK.

Farnell is a business unit of Avnet (Nasdaq: AVT). Avnet is a global technology solutions provider with an extensive ecosystem that delivers design, product, marketing and supply chain expertise for customers at every stage of the lifecycle.

For more information, visit the website at http://www.farnell.com/corporate


About Epilepsy Research UK

Epilepsy Research UK’s vision is ‘A life free from epilepsy’. Our mission is to drive and enable life changing, life saving research into epilepsy. We are the only UK charity exclusively dedicated to promoting, encouraging and funding research into the causes, diagnosis and treatments of epilepsy. In addition to funding research, we also work to develop the next generation of epilepsy researchers by capacity building the epilepsy research environment and accelerating innovations that will influence clinical practice and health policy. Our work is entirely funded from voluntary donations. You can find more information about Epilepsy Research UK here www.epilepsyresearch.org.uk.